UNIVERSITY OF WASHINGTON
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1861-01-01
- Employees
- 10K
- Market Cap
- -
Assessment of Socket Shapes Made by Central Fabrication Facilities
Completed
- Conditions
- People With Lower Limb Amputation That Are Ambulatory
- Interventions
- Other: Assessed for socket fit
- First Posted Date
- 2010-11-22
- Last Posted Date
- 2014-04-25
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 24
- Registration Number
- NCT01245504
- Locations
- 🇺🇸
University of Washington, Bioengineering Department, Seattle, Washington, United States
Lumbar Epidural Steroid Injections for Spinal Stenosis Multicenter Randomized, Controlled Trial (LESS Trial)
Phase 4
Completed
- Conditions
- Low Back PainSpinal Stenosis
- Interventions
- Procedure: Epidural steroid with local anesthetic injectionDrug: Epidural local anesthetic injectionDrug: Epidural steroid injection
- First Posted Date
- 2010-11-10
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 400
- Registration Number
- NCT01238536
- Locations
- 🇺🇸
Kaiser Permanente Northern California, Roseville, California, United States
🇺🇸Brigham and Women's Hospital, Boston, Massachusetts, United States
🇺🇸Dallas VA Medical Center, Dallas, Texas, United States
Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer
Phase 1
Withdrawn
- Conditions
- HER2-positive Breast CancerMale Breast CancerStage IV Breast Cancer
- Interventions
- Biological: HER-2/neu peptide vaccineDrug: cyclophosphamideBiological: ex vivo-expanded HER2-specific T cellsOther: laboratory biomarker analysisOther: flow cytometryOther: immunoenzyme technique
- First Posted Date
- 2010-10-13
- Last Posted Date
- 2013-05-17
- Lead Sponsor
- University of Washington
- Registration Number
- NCT01219907
- Locations
- 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States
MRI of the Liver With Eovist
Terminated
- Conditions
- Hepatocellular Carcinoma
- First Posted Date
- 2010-10-07
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 4
- Registration Number
- NCT01215838
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
Phase 1
Completed
- Conditions
- Healthy Males
- Interventions
- First Posted Date
- 2010-10-06
- Last Posted Date
- 2014-03-31
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 46
- Registration Number
- NCT01215292
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia Major
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 20
- Registration Number
- NCT01206075
- Locations
- 🇬🇷
George Papanicolaou Hospital, Thessaloniki, Greece
Optimization of Human Cortical Stimulation
- Conditions
- EpilepsyBrain Injury
- Interventions
- Procedure: Low-level cortical stimulation
- First Posted Date
- 2010-09-10
- Last Posted Date
- 2021-04-27
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 8
- Registration Number
- NCT01198964
- Locations
- 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial
Not Applicable
Completed
- Conditions
- Hiatal Hernia
- Interventions
- Device: Veritas® Collagen Matrix
- First Posted Date
- 2010-09-06
- Last Posted Date
- 2018-07-10
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 20
- Registration Number
- NCT01195545
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
Integrated Infectious Disease Capacity-Building Evaluation
Not Applicable
Completed
- Conditions
- Support for Midlevel Health ProfessionalsDiagnostic TrainingCapacity Building
- Interventions
- Behavioral: Training and SupervisionBehavioral: Integrated Management of Infectious Disease (IMID)
- First Posted Date
- 2010-08-27
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 72
- Registration Number
- NCT01190540
- Locations
- 🇺🇬
Infectious Disease Institute, Makerere University, Kampala, Uganda
Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)
Phase 2
Completed
- Conditions
- Chronic Posttraumatic Stress Disorder
- Interventions
- Drug: Psychotherapy plus Methylene Blue, USPBehavioral: Psychotherapy plus PlaceboBehavioral: Delayed Psychotherapy
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2017-06-14
- Lead Sponsor
- University of Washington
- Target Recruit Count
- 42
- Registration Number
- NCT01188694
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸University of Washington, Seattle, Washington, United States
🇺🇸University of Texas, Austin, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath